Kymera Therapeutics (KYMR) PT Raised to $118 at Leerink Partners
Tweet
Share
E-mailGet Alerts KYMR Hot Sheet
Price: $114.03 +4.02%
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
26 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Leerink Partners analyst Faisal Khurshid raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $118.00 (from $70.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Mannatech (MTEX) Tops Q2 EPS by 53c
- Aptera Motors (SEV) Reports Q2 Loss of $0.20
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
